Clinical trial / 2014
Ginkgo biloba extract did not improve visual field defect or contrast sensitivity in Chinese patients with normal tension glaucoma.
A randomized, placebo-controlled crossover trial evaluated the effect of Ginkgo biloba extract (40 mg, 3 times daily for 4 weeks) compared to placebo, separated by an 8-week washout period, in 35 patients with normal tension glaucoma. Among the 28 patients who completed testing, changes in visual field mean deviation and contrast sensitivity did not differ by treatment received or sequence (P > 0.2 for all). The authors concluded that Ginkgo biloba extract treatment had no effect on mean defect or contrast sensitivity in this group.
- Study type
- Randomized, placebo-controlled crossover trial
- Who was studied
- 35 Chinese patients (mean age 63.7 years) newly diagnosed with normal tension glaucoma
- What was measured
- Change in contrast sensitivity and visual field mean deviation; IOP and adverse events
THE PAPER
Effect of Ginkgo biloba on visual field and contrast sensitivity in Chinese patients with normal tension glaucoma: a randomized, crossover clinical trial.
Guo X, Kong X, Huang R, Jin L, Ding X, He M, Liu X, Patel MC, Congdon NG. Invest Ophthalmol Vis Sci, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.